ERBB2 and breast carcinoma: As for molecular types, there were 74 (17.7%) for luminal A, 206 (49.2%) for luminal B, 70 (16.7%) for Her-2 and 69 (16.5%) for triple-negtive (TN) subtype breast cancer.